Virology Journal is the official publication of the National Institute of Health which is headed by Dr Anthony Fauci.
In August 2005 the authors of a paper, that was sponsored by NIH, reported from their in vitro studies in primate cells that “chloroquine has strong antiviral effects on SARS-CoV infection” and that “these inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.”
Chloroquine or Hydroxychloroquine (HCQ), it’s milder form, should have been potential study candidates to prevent and treat SARS-CoV-2 from the beginning of the pandemic. This study suggests early timing is key.
Studies by official agencies, designed experiments to use the drug late – in hospital settings, and demonstrated this timing to be ineffective – no surprise there. Which is contrary to how frontline doctors used it in the very early stages of virual infection and they reported great success.
Why did officials push vaccines from the beginning when science held this information, albeit anecdotal, but important?
The authors stated that “concentrations of 10 uM completely abolished SARS-CoV infection. What other viruses could this cheap, off-patent drug work against, and what effect would that have on the pharmaceutical market?